| Name | Title | Contact Details |
|---|---|---|
Marcie Matthews |
Chief Operating Officer | Profile |
Mercyhealth is a regional health system with over 700 employed physician partners, seven hospitals and 85 primary and specialty care locations throughout 50 northern Illinois and southern Wisconsin communities. We are committed to being a top integrated health care provider and continuously work to make life better for the people, families and communities we serve. As an integrated health care provider, we provide exceptional, coordinated health care that spans four core service divisions: hospital-based services, clinic-based services, post-acute care and retail services, and a wholly owned insurance company. These four core service divisions make up our comprehensive, vertically integrated delivery system, and integrated delivery is what makes Mercyhealth unique in serving the full range of health care needs for our patients. Every day, our 8,000+ employee take to heart our passion for making lives better. Our providers, nurses and partners are committed to working together to make lives better for our patients and their families. Touching lives invigorates, inspires and drives us to do our very best, and we continuously look for ways to make each life better with the utmost care and professionalism. This can be as complex as a cutting-edge procedure or as simple as a smile. Nothing is ever too small or taken for granted. Everything matters. And we never miss a beat.
Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.
National Surgical Adjuvant Breast and Bowel is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Precept Medical Communications is a Warren, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Accutek Testing Laboratory is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.